v3.24.2.u1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at the beginning of period at Dec. 31, 2022 $ 4 $ 543,929 $ 1,331 $ (436,043) $ 109,221
Balance at the beginning of period (in shares) at Dec. 31, 2022 43,670,109        
Increase (Decrease) in Stockholders' Equity          
Stock-based compensation expense   5,304     5,304
Stock-based compensation expense (in shares) 7,658        
Foreign currency translation     (306)   (306)
Net Income (Loss)       (6,390) (6,390)
Balance at the end of period at Mar. 31, 2023 $ 4 549,233 1,025 (442,433) 107,829
Balance at the end of period (in shares) at Mar. 31, 2023 43,677,767        
Balance at the beginning of period at Dec. 31, 2022 $ 4 543,929 1,331 (436,043) 109,221
Balance at the beginning of period (in shares) at Dec. 31, 2022 43,670,109        
Increase (Decrease) in Stockholders' Equity          
Net Income (Loss)         (12,692)
Balance at the end of period at Jun. 30, 2023 $ 4 552,369 1,043 (448,735) 104,681
Balance at the end of period (in shares) at Jun. 30, 2023 43,620,192        
Balance at the beginning of period at Mar. 31, 2023 $ 4 549,233 1,025 (442,433) 107,829
Balance at the beginning of period (in shares) at Mar. 31, 2023 43,677,767        
Increase (Decrease) in Stockholders' Equity          
Retirement of treasury shares   (480)     (480)
Retirement of treasury shares (in shares) (58,763)        
Stock-based compensation expense   3,616     3,616
Stock-based compensation expense (in shares) 1,188        
Foreign currency translation     18   18
Net Income (Loss)       (6,302) (6,302)
Balance at the end of period at Jun. 30, 2023 $ 4 552,369 1,043 (448,735) 104,681
Balance at the end of period (in shares) at Jun. 30, 2023 43,620,192        
Balance at the beginning of period at Dec. 31, 2023 $ 4 558,002 449 (457,470) $ 100,985
Balance at the beginning of period (in shares) at Dec. 31, 2023 43,672,112       43,672,112
Increase (Decrease) in Stockholders' Equity          
Exercise of stock options   588     $ 588
Exercise of stock options (in shares) 71,550        
Stock-based compensation expense   3,846     3,846
Stock-based compensation expense (in shares) 108,976        
Foreign currency translation     399   399
Net Income (Loss)       (6,629) (6,629)
Balance at the end of period at Mar. 31, 2024 $ 4 562,436 848 (464,099) 99,189
Balance at the end of period (in shares) at Mar. 31, 2024 43,852,638        
Balance at the beginning of period at Dec. 31, 2023 $ 4 558,002 449 (457,470) $ 100,985
Balance at the beginning of period (in shares) at Dec. 31, 2023 43,672,112       43,672,112
Increase (Decrease) in Stockholders' Equity          
Exercise of stock options (in shares)         771,047
Net Income (Loss)         $ (15,878)
Balance at the end of period at Jun. 30, 2024 $ 4 567,633 1,047 (473,348) $ 95,336
Balance at the end of period (in shares) at Jun. 30, 2024 44,567,334       44,567,334
Balance at the beginning of period at Mar. 31, 2024 $ 4 562,436 848 (464,099) $ 99,189
Balance at the beginning of period (in shares) at Mar. 31, 2024 43,852,638        
Increase (Decrease) in Stockholders' Equity          
Exercise of stock options   1,758     1,758
Exercise of stock options (in shares) 699,497        
Stock-based compensation expense   3,439     3,439
Stock-based compensation expense (in shares) 15,199        
Foreign currency translation     199   199
Net Income (Loss)       (9,249) (9,249)
Balance at the end of period at Jun. 30, 2024 $ 4 $ 567,633 $ 1,047 $ (473,348) $ 95,336
Balance at the end of period (in shares) at Jun. 30, 2024 44,567,334       44,567,334